Treatment of non-severe hemoptysis: A retrospective propensity score-matched comparison between conservative management and bronchial artery embolization
European Journal of Radiology · 2026
DOI: 10.1016/j.ejrad.2025.112604 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Radiology, 2026. Verfasst von Kun Yung Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-…. Hauptthemen laut MEDLINE: Hemoptysis, Embolization, Therapeutic, Bronchial Arteries, Conservative Treatment. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Center for Inter-University Research Facilities.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to compare the effectiveness of hemoptysis control between patients managed conservatively and early bronchial artery embolization (BAE), and to identify clinical factors associated with recurrence. METHODS: Patients with underlying malignancy, massive hemoptysis, or incomplete clinical data were excluded. 320 patients with non-severe hemoptysis were included (210 conservative, 110 BAE). Propensity scores were estimated using baseline variables including age, sex, comorbidities, and radiologic findings. Hemoptysis-free survival (HFS) was the primary outcome. Cox proportional hazards regression was used to assess associations between clinical and radiological factors and HFS. RESULTS: Before PSM, radiological finding of post-tuberculous residual changes and cavitary lesion were more prevalent in the BAE group (22.7 % vs. 13.3 %, p = 0.032; 12.7 % vs. 5.7 %, p = 0.029, respectively).After PSM, 110 matched pairs showed balanced baseline variables. Clinical success rates were 94.5 % in the conservative group and 97.3 % in the BAE group (p = 0.496). In the PSM cohort, HFS did not differ significantly between groups (p = 0.304). Diabetes mellitus (DM) was the only independent predictor of recurrence (HR 2.615, 95 % CI 1.288-5.306, p = 0.008). Patients with DM had significantly shorter HFS (p = 0.003). CONCLUSION: Conservative management and BAE showed comparable outcomes in non-severe hemoptysis of benign etiology. Diabetes mellitus was an independent predictor of recurrence, and BAE served effectively as rescue therapy after conservative treatment failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, South Korea.
- Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, South Korea. Electronic address: y…
Förderung
- National Center for Inter-University Research Facilities
Zitieren
APA
Kim, K. Y., Yoon, C. J., Lee, J. H., Lee, C. H., & Min, H. D. (2026). Treatment of non-severe hemoptysis: A retrospective propensity score-matched comparison between conservative management and bronchial artery embolization. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112604
Vancouver
Kim KY, Yoon CJ, Lee JH, Lee CH, Min HD. Treatment of non-severe hemoptysis: A retrospective propensity score-matched comparison between conservative management and bronchial artery embolization. European Journal of Radiology. 2026. doi:10.1016/j.ejrad.2025.112604
BibTeX
@article{Kim2026,
author = {Kim, Kun Yung and Yoon, Chang Jin and Lee, Jae Hwan and Lee, Chong-Ho and Min, Hooney Daniel},
title = {Treatment of non-severe hemoptysis: A retrospective propensity score-matched comparison between conservative management and bronchial artery embolization},
journal = {European Journal of Radiology},
year = {2026},
doi = {10.1016/j.ejrad.2025.112604}
}
EUVIMED